We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 420 results
  1. Lymph node ratio and hematological parameters predict relapse-free survival in patients with high grade rectal neuroendocrine neoplasms after radical resection: a multicenter prognostic study

    Background

    The prognostic nutritional index (PNI), alkaline phosphatase (ALP), and lymph node ratio (LNR) are reportedly related to prognosis. The aim...

    **nyu Zeng, Peng Zhang, ... Kaixiong Tao in World Journal of Surgical Oncology
    Article Open access 22 September 2023
  2. Gastric NEN. III-2. Staging and Treatment

    Gastric NENs are biologically different from gastric adenocarcinoma. For gastric NEMs, two staging systems for gastric NENs have been established:...
    Hoon Jai Chun, Seun Ja Park, ... Si Young Song in Gastrointestinal Cancer
    Chapter 2023
  3. A relook at gastroenteropancreatic neuroendocrine tumours as per 2019 WHO classification—A tertiary centre experience

    Introduction

    Neuroendocrine neoplasm of GIT (gastrointestinal tract) and pancreas is heterogenous with variable clinical features and disease...

    Divya Achutha Ail, Roopa Rachel Paulose in Irish Journal of Medical Science (1971 -)
    Article 21 November 2022
  4. What have we learnt from the past – would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?

    Background

    Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of tumors with a broad range of local and systemic...

    Rahel Stiefel, Kuno Lehmann, ... Alexander R. Siebenhüner in BMC Cancer
    Article Open access 13 February 2023
  5. Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

    Background

    The use of liver transplantation (LT) in patients with stage IV neuroendocrine pancreatic tumors (pan-NET) is under debate. Previous...

    Josefine Kjaer, Sara Smith, ... Olov Norlén in World Journal of Surgery
    Article Open access 29 September 2022
  6. Pancreatic Neuroendocrine Neoplasms. V-2. Staging and Treatment

    The term pancreatic neuroendocrine neoplasm (PNEN) encompasses a diverse set of tumors arising in the pancreas neuroendocrine progenitor cell. PNEN...
    Hoon Jai Chun, Seun Ja Park, ... Si Young Song in Gastrointestinal Cancer
    Chapter 2023
  7. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma

    Objective

    To establish a novel nomogram to predict individual 1, 3, and 5 years disease-free survival (DFS) of patients with gastric neuroendocrine...

    Hualong Zheng, YaJun Zhao, ... Changming Huang in Gastric Cancer
    Article 11 September 2020
  8. Diagnostic Applications of Nuclear Medicine: Neuroendocrine Tumors

    Neuroendocrine tumors (NETs) originate from neuroendocrine cells ubiquitously distributed throughout the body and occur mainly in the...
    Lisa Bodei, Vetri Sudar Jayaprakasam, ... Irvin M. Modlin in Nuclear Oncology
    Living reference work entry 2022
  9. Diagnostic Applications of Nuclear Medicine: Neuroendocrine Tumors

    Neuroendocrine tumors (NETs) originate from neuroendocrine cells ubiquitously distributed throughout the body and occur mainly in the...
    Lisa Bodei, Vetri Sudar Jayaprakasam, ... Irvin M. Modlin in Nuclear Oncology
    Reference work entry 2022
  10. Prophylactic cholecystectomy is not mandatory in patients candidate to the resection for small intestine neuroendocrine neoplasms: a propensity score-matched and cost-minimization analysis

    To evaluate two competitive strategies in patients undergoing resection of Small-intestine neuroendocrine neoplasms (Si-NEN): prophylactic...

    Carlo Ingaldi, Laura Alberici, ... Riccardo Casadei in Updates in Surgery
    Article Open access 05 July 2021
  11. Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification

    Background

    The prognostic values of inflammation-based markers in well-differentiated pancreatic neuroendocrine neoplasms, diagnosed according to the...

    Takayuki Miura, Hideo Ohtsuka, ... Michiaki Unno in BMC Surgery
    Article Open access 31 March 2021
  12. Co-existing Neuroendocrine Tumors in the Ileum and Pancreas: A Clinico-Pathological Challenge

    Ileal (I) and pancreatic (Pan) neuroendocrine tumors (NETs) are among the most common digestive neuroendocrine neoplasms (NENs). Coexisting NETs at...

    Alice Laffi, Alexia Francesca Bertuzzi, ... Silvia Uccella in Endocrine Pathology
    Article 07 June 2024
  13. Staging and Treatment. II-1. Staging and Prognosis

    Accurate diagnosis and/or staging of appendiceal tumors is essential due to recent advances in treatment. However, the classification and terms of...
    Hoon Jai Chun, Seun Ja Park, ... Si Young Song in Gastrointestinal Cancer
    Chapter 2023
  14. Staging and Treatment. II-2. Overview of Treatment According to Stage

    The prognosis and treatment of appendiceal cancer differ according to histological type. There is controversy regarding the treatment strategy owing...
    Hoon Jai Chun, Seun Ja Park, ... Si Young Song in Gastrointestinal Cancer
    Chapter 2023
  15. From morphology to molecular targets—the pathologist’s view in diagnosing gastroenteropancreatic neuroendocrine neoplasms

    In the last decade, a number of genetic alterations in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have been identified. In addition,...

    Hanna Henzinger, Iva Brcic in memo - Magazine of European Medical Oncology
    Article Open access 24 October 2022
  16. Appendiceal Tumors

    Appendiceal adenocarcinoma was first described by Berger in 1882 [1], whereas a tumor arising from neuroendocrine cells [neuroendocrine tumors...
    Gaetano Gallo, Marta Goglia, ... Salomone Di Saverio in Oncologic Surgical Emergencies
    Chapter 2023
  17. Prognostic significance of laterality in lung neuroendocrine tumors

    Purpose:

    Well-differentiated lung neuroendocrine tumors (Lu-NET) are classified as typical (TC) and atypical (AC) carcinoids, based on mitotic counts...

    Anna La Salvia, Irene Persano, ... Antongiulio Faggiano in Endocrine
    Article Open access 18 March 2022
  18. Grading Solid Pseudopapillary Tumors of the Pancreas: the Fudan Prognostic Index

    Background

    Ki-67 has been shown to predict outcome of patients with solid pseudopapillary tumor of the pancreas (SPTP) but has not been incorporated...

    Feng Yang, Wenchuan Wu, ... Deliang Fu in Annals of Surgical Oncology
    Article 18 May 2020
  19. Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence

    Background

    Surgery with radical intent is the only potentially curative option for entero-pancreatic neuroendocrine tumors (EP-NETs) but many patients...

    E. Merola, A. Pascher, ... M. E. Pavel in Annals of Surgical Oncology
    Article 18 May 2022
  20. Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors

    Background

    Lung NET, classified in typical carcinoids (TC) and atypical carcinoids (AC), are highly heterogeneous in their biology and prognosis. The...

    A. La Salvia, B. Marcozzi, ... A. Faggiano in Journal of Endocrinological Investigation
    Article 23 March 2024
Did you find what you were looking for? Share feedback.